Genetic imaging consortium for addiction medicine: From neuroimaging to genes

Affiliations

• ¹ Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA. Electronic address: msmackey@uvm.edu.
• ² Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA.
• ³ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ⁴ Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain; Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
• ⁵ Department of Psychiatry and MRC Unit on Anxiety & Stress Disorders, University of Cape Town, Cape Town, South Africa.
• ⁶ Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
• ⁷ Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ⁸ Institute of Psychiatry, King's College London, London, UK.
• ⁹ Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
• ¹⁰ Department of Psychiatry and MRC Unit on Anxiety & Stress Disorders, University of Cape Town, Cape Town, South Africa; Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
• ¹¹ Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
• ¹² Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
• ¹³ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
• ¹⁴ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
• ¹⁵ School of Psychological Sciences, Monash Institute of Cognitive and Clinical Neurosciences and Monash Biomedical Imaging, Monash University, Melbourne, Australia.
• ¹⁶ Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
• ¹⁷ Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain.
• ¹⁸ David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
• ¹⁹ VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, CA, USA; Laureate Institute for Brain Research, Tulsa, OK, USA.
• ²⁰ Rotman Research Institute, University of Toronto, Toronto, ON, Canada.
• ²¹ Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
• ²² Section on Brain Electrophysiology and Imaging, Institute on Alcohol Abuse and Alcoholism, Bethesda, USA.
• ²³ Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
• ²⁴ Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
• ²⁵ Intramural Research Program-Neuroimaging Research Branch, National Institute on Drug Abuse, Baltimore, MD, USA.
• ²⁶ School of Psychology, University of Wollongong, Wollongong, NSW, Australia.
• ²⁷ Laureate Institute for Brain Research, Tulsa, OK, USA.
• ²⁸ Department of Psychiatry and Psychotherapy, Charité Universitatsmedizin, Berlin, Germany.
• ²⁹ QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
• ³⁰ Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
• ³¹ Department of Neurology, Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
• ³² Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada.